CytomX Therapeutics (CTMX) EBITDA Margin Growth (3y) (2017 - 2026)
CytomX Therapeutics (CTMX) EBITDA Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CytomX Therapeutics | 590.32 Mn | 243.61 Mn | - | -16,772.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16,772.00 |
| Dec 31, 2025 | -416,572.00 |
| Sep 30, 2025 | 210.00 |
| Jun 30, 2025 | 22,694.00 |
| Mar 31, 2025 | 39,910.00 |
| Dec 31, 2024 | 35,995.00 |
| Sep 30, 2024 | 35,008.00 |
| Jun 30, 2024 | 26,991.00 |
| Mar 31, 2024 | 31,360.00 |
| Dec 31, 2023 | 33,785.00 |
| Sep 30, 2023 | 34,959.00 |
| Jun 30, 2023 | 35,506.00 |
| Mar 31, 2023 | -1,235.00 |
| Dec 31, 2022 | 77,370.00 |
| Sep 30, 2022 | -2,644.00 |
| Jun 30, 2022 | 11,270.00 |
| Mar 31, 2022 | -26,315.00 |
| Dec 31, 2021 | -8,853.00 |
| Sep 30, 2021 | -15,250.00 |
| Jun 30, 2021 | -16,965.00 |